Matches in Wikidata for { <http://www.wikidata.org/entity/Q64614064> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64614064 description "clinical trial" @default.
- Q64614064 description "ensayu clínicu" @default.
- Q64614064 description "klinisch onderzoek" @default.
- Q64614064 description "клінічне випробування" @default.
- Q64614064 name "A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)" @default.
- Q64614064 type Item @default.
- Q64614064 label "A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)" @default.
- Q64614064 prefLabel "A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)" @default.
- Q64614064 P1132 Q64614064-9084E4A8-6513-4E7A-83E4-2508FAF2377D @default.
- Q64614064 P1476 Q64614064-6529C8FF-AC33-4D38-9DBE-D19617498627 @default.
- Q64614064 P17 Q64614064-0D58DDD0-E2C9-4096-8153-0C40D9059DAD @default.
- Q64614064 P17 Q64614064-1B71EE1B-70DF-4760-B741-8C42272A679B @default.
- Q64614064 P17 Q64614064-2F53F8F5-A9F2-44A3-B222-53485141C397 @default.
- Q64614064 P17 Q64614064-5070E6D8-9455-42F5-A60F-85A793934319 @default.
- Q64614064 P1813 Q64614064-57FA1439-77EC-4729-B02C-75CC5B94A349 @default.
- Q64614064 P2899 Q64614064-C2028EA6-D981-4F93-A6EC-D2E08D3A1FBD @default.
- Q64614064 P3098 Q64614064-8DB73F43-92F6-4782-BD3D-91D99130D363 @default.
- Q64614064 P31 Q64614064-F7CC9C84-DA1A-4FEC-97DB-A75600F53A18 @default.
- Q64614064 P580 Q64614064-690F60F0-26BC-41B4-933A-E945A47D08C1 @default.
- Q64614064 P582 Q64614064-05014315-E402-421C-BE6B-697B0A941D4C @default.
- Q64614064 P6099 Q64614064-00C694A3-4A7E-4828-A1AF-68E397404BF5 @default.
- Q64614064 P6099 Q64614064-1FCB6CF6-294C-443D-8DC4-31156E25DD7F @default.
- Q64614064 P6153 Q64614064-5151703B-8573-406B-B800-471DECB7CCF2 @default.
- Q64614064 P6153 Q64614064-7D51BF8E-01DF-4CFD-9436-44EF6DF8232C @default.
- Q64614064 P6153 Q64614064-9082C8EE-A29F-468D-BDA0-360FE262B94F @default.
- Q64614064 P8363 Q64614064-1AD3C5E6-ECC9-457C-A107-F199A3AE4486 @default.
- Q64614064 P1132 "+118" @default.
- Q64614064 P1476 "A EUROPEAN, MULTICENTRE, PHASE II/III RANDOMISED DOUBLE-BLIND, PLACEBO CONTROLLED STUDY EVALUATING LANREOTIDE AS MAINTENANCE THERAPY IN PATIENTS WITH NON-RESECTABLE DUODENO-PANCREATIC NEUROENDOCRINE TUMOURS AFTER FIRST-LINE TREATMENT" @default.
- Q64614064 P17 Q142 @default.
- Q64614064 P17 Q145 @default.
- Q64614064 P17 Q183 @default.
- Q64614064 P17 Q31 @default.
- Q64614064 P1813 "REMINET" @default.
- Q64614064 P2899 "+18" @default.
- Q64614064 P3098 "NCT02288377" @default.
- Q64614064 P31 Q30612 @default.
- Q64614064 P580 "2015-01-01T00:00:00Z" @default.
- Q64614064 P582 "2019-12-01T00:00:00Z" @default.
- Q64614064 P6099 Q42824440 @default.
- Q64614064 P6099 Q42824827 @default.
- Q64614064 P6153 Q1131080 @default.
- Q64614064 P6153 Q155354 @default.
- Q64614064 P6153 Q266227 @default.
- Q64614064 P8363 Q78089383 @default.